[Efficacy and compatibility of bumadizone-Ca in rheumatoid diseases. A comparison with oxyphenbutazone].
D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D020968:Brachial Plexus Neuritis / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004342:Drug Hypersensitivity; D004361:Drug Tolerance; D005260:Female; D005767:Gastrointestinal Diseases / Q000139:chemically induced; D006801:Humans; D008297:Male; D008314:Malonates / Q000009:adverse effects / Q000627:therapeutic use*; D010113:Oxyphenbutazone / Q000627:therapeutic use; D010146:Pain / Q000188:drug therapy; D010659:Phenylhydrazines / Q000009:adverse effects / Q000627:therapeutic use*; D011111:Polymyalgia Rheumatica / Q000188:drug therapy; D012216:Rheumatic Diseases / Q000188:drug therapy*; D013117:Spinal Cord Compression / Q000188:drug therapy; D013122:Spinal Diseases / Q000188:drug therapy; D013167:Spondylitis, Ankylosing / Q000188:drug therapy
D000893:Anti-Inflammatory Agents; D008314:Malonates; D010659:Phenylhydrazines; D010113:Oxyphenbutazone
Wirksamkeit und Verträglichkeit von Bumadizon-Ca bei Erkrankungen des rheumatischen formenkreises. Vergleich mit Oxyphenbutazon.